Research and Markets: U.S. Market for X-Ray, Mammography and Contrast Agents 2010

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/7acc75/u_s_market_for_x) has announced the addition of the "U.S. Market for X-Ray, Mammography and Contrast Agents 2010" report to their offering.

In 2009, the U.S. market for X-ray, mammography and contrast agents was valued at over $5 billion. The medical imaging equipment market includes X-rays, mammography as well as contrast agents and injectors. The market declined in 2009 due to the deficit reduction act, which limited reimbursement for some imaging modalities. In addition, the global economic recession of 2008 to 2009 negatively impacted the market; however, the market is expected to recover beginning in 2010.

This market includes:

  • Analog X-ray
  • Computed Radiography X-ray
  • Digital Radiography X-ray
  • Fluoroscopy
  • Cardiovascular X-ray
  • Orthopedic X-ray
  • Analog Mammography
  • Computed Radiography Mammography
  • Digital Radiography Mammography
  • BSGI Mammography
  • PEM Mammography
  • X-Ray/CT Contrast Agents
  • MRI Contrast Agents
  • Ultrasound Contrast Agents
  • Contrast Injector

Within the X-ray, mammography and contrast agent market, companies such as Bracco, Bayer Healthcare Pharmaceuticals, Covidien, Fujifilm, GE Healthcare, Philips Healthcare and Siemens Healthcare lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.

Keywords: imaging, x-ray, mammography, contrast agents, analog x-ray, computed radiography, digital radiography, fluoroscopy, cardiovascular, orthopedic, positron emission mammography.

Key Topics Covered:

  • EXECUTIVE SUMMARY
  • RESEARCH METHODOLOGY
  • U.S. X-RAY, MAMMOGRAPHY AND CONTRAST AGENT MARKET
  • X-RAY IMAGING MARKET
  • MAMMOGRAPHY IMAGING MARKET
  • CONTRAST AGENT AND INJECTOR MARKET

For more information visit http://www.researchandmarkets.com/research/7acc75/u_s_market_for_x



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:   Europe  Ireland

INDUSTRY KEYWORDS:   Health  General Health

MEDIA:

Logo
 Logo

Suggested Articles

It’s been a rocky road for BMS’ immuno-oncology duo in previously untreated lung cancer, but a new addition to the regimen might hold the ticket.

Novartis’ Zolgensma launch has been anything but boring: First a record price, then a data scandal and now a manufacturing-related delay in Europe.

As CEO Paul Hudson focuses Sanofi's R&D program on immuno-oncology and gene therapies, Sanofi is readying a vaccine plant to make viral vectors.